ArticleMedical oncology (Northwood, London, England)2025
Antitumor effects of morphine and tramadol on lung metastasis of melanoma tumor cells in vitro and in vivo.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Morphine and tramadol are analgesic agents commonly employed in the management of cancer pain. Morphine’s effects on tumor cell growth can be either inhibitory or stimulatory, depending on various factors; however, data regarding tramadol’s impact on melanoma is lacking. The present study aimed to compare the effects of morphine and tramadol on melanoma cells both in vitro and in vivo, to provide further insights into their potential as adjuvant therapeutic agents in melanoma management. Both drugs demonstrated dose-dependent cytotoxicity against B16F10 melanoma cells, achieving a maximum effect of 80% at a concentration of 5.0 μM. Notably, at this concentration, morphine induced greater apoptosis (49%) compared to tramadol (37%). In clonogenic assays, tramadol (0.5 μM) inhibited colony formation by 80%, whereas morphine at the same concentration completely (100%) inhibited colony formation. Both morphine and tramadol significantly reduced the formation of metastases in mice (p < 0.05), with morphine showing a greater reduction in lung tumorigenicity compared to tramadol (p < 0.05). Furthermore, the combination of tramadol at a clinical dose (2.00 μM) with cisplatin (0.0312 μM) enhanced inhibition of cell proliferation compared to cisplatin alone (p < 0.05). In summary, data from in vivo experiments indicated that both drugs induced a significant reduction in tumor size, as well as in the number of metastases. However, morphine was more effective than tramadol. Further research is needed to evaluate antitumor effects of clinical doses of morphine and to explore the potential of tramadol as a substitute for morphine as adjuvant drug in antitumor treatment and pain management of melanoma patients.
Indexed as
Identifiers
41452437What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.